|
1
|
Omata M, Lesmana LA, Tateishi R, Chen PJ,
Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, et al: Asian
Pacific Association for the Study of the Liver consensus
recommendations on hepatocellular carcinoma. Hepatol Int.
4:439–474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Borie F, Bouvier AM, Herrero A, Faivre J,
Launoy G, Delafosse P, Velten M, Buemi A, Peng J, Grosclaude P and
Trétarre B: Treatment and prognosis of hepatocellular carcinoma: A
population based study in France. J Surg Oncol. 98:505–509. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Poon RT, Fan ST, Tsang FH and Wong J:
Locoregional therapies for hepatocellular carcinoma: A critical
review from the surgeon's perspective. Ann Surg. 235:466–486. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Curley SA, Izzo F, Ellis LM, Vauthey J
Nicolas and Vallone P: Radiofrequency ablation of hepatocellular
cancer in 110 patients with cirrhosis. Ann Surg. 232:381–391. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Poon RT, Ng KK, Lam CM, Ai V, Yuen J and
Fan ST: Radiofrequency ablation for subcapsular hepatocellular
carcinoma. Ann Surg Oncol. 11:281–289. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lü MD, Kuang M, Liang LJ, Xie XY, Peng BG,
Liu GJ, Li DM, Lai JM and Li SQ: Surgical resection versus
percutaneous thermal ablation for early-stage hepatocellular
carcinoma: A randomized clinical trial. Zhonghua Yi Xue Za Zhi.
86:801–805. 2006.(In Chinese). PubMed/NCBI
|
|
7
|
Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH,
Zhang YQ, Lin XJ and Lau WY: A prospective randomized trial
comparing percutaneous local ablative therapy and partial
hepatectomy for small hepatocellular carcinoma. Ann Surg.
243:321–328. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livraghi T, Meloni F, Di Stasi M, Rolle E,
Solbiati L, Tinelli C and Rossi S: Sustained complete response and
complications rates after radiofrequency ablation of very early
hepatocellular carcinoma in cirrhosis: Is resection still the
treatment of choice? Hepatology. 47:82–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kao WY, Chiou YY, Hung HH, Chou YH, Su CW,
Wu JC, Huo TI, Huang YH, Lin HC and Lee SD: Risk factors for
long-term prognosis in hepatocellular carcinoma after
radiofrequency ablation therapy: The clinical implication of
aspartate aminotransferase-platelet ratio index. Eur J
Gastroenterol Hepatol. 23:528–536. 2011.PubMed/NCBI
|
|
10
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Forrest LM, McMillan DC, McArdle CS,
Angerson WJ and Dunlop DJ: Comparison of an inflammation-based
prognostic score (GPS) with performance status (ECOG) in patients
receiving platinum-based chemotherapy for inoperable non-small-cell
lung cancer. Br J Cancer. 90:1704–1706. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramsey S, Lamb GW, Aitchison M, Graham J
and McMillan DC: Evaluation of an inflammation-based prognostic
score in patients with metastatic renal cancer. Cancer.
109:205–212. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ishizuka M, Nagata H, Takagi K, Horie T
and Kubota K: Inflammation-based prognostic score is a novel
predictor of postoperative outcome in patients with colorectal
cancer. Ann Surg. 246:1047–1051. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang ZL, Luo J, Chen MS, Li JQ and Shi M:
Blood neutrophil-to-lymphocyte ratio predicts survival in patients
with unresectable hepatocellular carcinoma undergoing transarterial
chemoembolization. J Vasc Interv Radiol. 22:702–709. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Halazun KJ, Hardy MA, Rana AA, DC IV
Woodland, Luyten EJ, Mahadev S, Witkowski P, Siegel AB, Brown RS Jr
and Emond JC: Negative impact of neutrophil-lymphocyte ratio on
outcome after liver transplantation for hepatocellular carcinoma.
Ann Surg. 250:141–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gomez D, Farid S, Malik HZ, Young AL,
Toogood GJ, Lodge JP and Prasad KR: Preoperative
neutrophil-to-lymphocyte ratio as a prognostic predictor after
curative resection for hepatocellular carcinoma. World J Surg.
32:1757–1762. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bertuzzo VR, Cescon M, Ravaioli M, Grazi
GL, Ercolani G, Del Gaudio M, Cucchetti A, D'Errico-Grigioni A,
Golfieri R and Pinna AD: Analysis of factors affecting recurrence
of hepatocellular carcinoma after liver transplantation with a
special focus on inflammation markers. Transplantation.
91:1279–1285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kinoshita A, Onoda H, Imai N, Iwaku A,
Oishi M, Fushiya N, Koike K, Nishino H and Tajiri H: Comparison of
the prognostic value of inflammation-based prognostic scores in
patients with hepatocellular carcinoma. Br J Cancer. 107:988–993.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oken MM, Creech RH, Tormey DC, Horton J,
Davis TE, McFadden ET and Carbone PP: Toxicity and response
criteria of the Eastern Cooperative Oncology Group. Am J Clin
Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pugh RN, Murray-Lyon IM, Dawson JL,
Pietroni MC and Williams R: Transection of the oesophagus for
bleeding oesophageal varices. Br J Surg. 60:646–649. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McMillan DC, Canna K and McArdle CS:
Systemic inflammatory response predicts survival following curative
resection of colorectal cancer. Br J Surg. 90:215–219. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY,
Cho JY and Kim YR: Comparison of two inflammation-based prognostic
scores in patients with unresectable advanced gastric cancer.
Oncology. 83:292–299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sarraf KM, Belcher E, Raevsky E, Nicholson
AG, Goldstraw P and Lim E: Neutrophil/lymphocyte ratio and its
association with survival after complete resection in non-small
cell lung cancer. J Thorac Cardiovasc Surg. 137:425–428. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharaiha RZ, Halazun KJ, Mirza F, Port JL,
Lee PC, Neugut AI, Altorki NK and Abrams JA: Elevated preoperative
neutrophil: Lymphocyte ratio as a predictor of postoperative
disease recurrence in esophageal cancer. Ann Surg Oncol.
18:3362–3369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang D, Yang JX, Cao DY, Wan XR, Feng FZ,
Huang HF, Shen K and Xiang Y: Preoperative neutrophil-lymphocyte
and platelet-lymphocyte ratios as independent predictors of
cervical stromal involvement in surgically treated endometrioid
adenocarcinoma. Onco Targets Ther. 6:211–216. 2013.PubMed/NCBI
|
|
29
|
Jiang N, Deng JY, Liu Y, Ke B, Liu HG and
Liang H: The role of preoperative neutrophil-lymphocyte and
platelet-lymphocyte ratio in patients after radical resection for
gastric cancer. Biomarkers. 19:444–451. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kwon HC, Kim SH, Oh SY, Lee S and Lee JH,
Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ and Lee JH: Clinical
significance of preoperative neutrophil-lymphocyte versus
platelet-lymphocyte ratio in patients with operable colorectal
cancer. Biomarkers. 17:216–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Feng JF, Huang Y and Liu JS: Combination
of neutrophil lymphocyte ratio and platelet lymphocyte ratio is a
useful predictor of postoperative survival in patients with
esophageal squamous cell carcinoma. Onco Targets Ther. 6:1605–1612.
2013.PubMed/NCBI
|
|
32
|
Ishizuka M, Nagata H, Takagi K, Iwasaki Y
and Kubota K: Combination of platelet count and neutrophil to
lymphocyte ratio is a useful predictor of postoperative survival in
patients with colorectal cancer. Br J Cancer. 109:401–407. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
DeNardo DG, Johansson M and Coussens LM:
Immune cells as mediators of solid tumor metastasis. Cancer
Metastasis Rev. 27:11–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer: Links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alison MR, Nicholson LJ and Lin WR:
Chronic inflammation and hepatocellular carcinoma. Recent Results
Cancer Res. 185:135–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kusumanto YH, Dam WA, Hospers GA, Meijer C
and Mulder NH: Platelets and granulocytes, in particular the
neutrophils, form important compartments for circulating vascular
endothelial growth factor. Angiogenesis. 6:283–287. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu
Z, Yin XY and Zheng L: Peritumoral neutrophils link inflammatory
response to disease progression by fostering angiogenesis in
hepatocellular carcinoma. J Hepatol. 54:948–955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Paramanathan A, Saxena A and Morris DL: A
systematic review and meta-analysis on the impact of pre-operative
neutrophil lymphocyte ratio on long term outcomes after curative
intent resection of solid tumours. Surg Oncol. 23:31–39. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Egan K, Crowley D, Smyth P, O'Toole S,
Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, et
al: Platelet adhesion and degranulation induce pro-survival and
pro-angiogenic signalling in ovarian cancer cells. PLoS One.
6:e261252011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stone RL, Nick AM, McNeish IA, Balkwill F,
Han HD, Bottsford-Miller J, Rupairmoole R, Armaiz-Pena GN, Pecot
CV, Coward J, et al: Paraneoplastic thrombocytosis in ovarian
cancer. N Engl J Med. 366:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kitayama J, Yasuda K, Kawai K, Sunami E
and Nagawa H: Circulating lymphocyte number has a positive
association with tumor response in neoadjuvant chemoradiotherapy
for advanced rectal cancer. Radiat Oncol. 5:472010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J,
Tung H, Tso WK, Fan ST and Poon RT: Risk factors and prognostic
factors of local recurrence after radiofrequency ablation of
hepatocellular carcinoma. J Am Coll Surg. 207:20–29. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang B, Zou J, Xia J, Ren Z, Gan Y, Wang
Y, Zhang B, Ge N, Wang D, Chen Y, et al: Risk factors for
recurrence of small hepatocellular carcinoma after long-term
follow-up of percutaneous radiofrequency ablation. Eur J Radiol.
79:196–200. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim YS, Rhim H, Cho OK, Koh BH and Kim Y:
Intrahepatic recurrence after percutaneous radiofrequency ablation
of hepatocellular carcinoma: Analysis of the pattern and risk
factors. Eur J Radiol. 59:432–441. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lu DS, Raman SS, Limanond P, Aziz D,
Economou J, Busuttil R and Sayre J: Influence of large peritumoral
vessels on outcome of radiofrequency ablation of liver tumors. J
Vasc Interv Radiol. 14:1267–1274. 2003. View Article : Google Scholar : PubMed/NCBI
|
